About
Respicardia develops implantable phrenic nerve stimulation devices for the treatment of moderate to severe central sleep apnea in adults, aiming to restore normal breathing patterns during sleep.
Explore Respicardia's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.